HCPCS code J2267 — Inj, mirikizumab-mrkz, 1 mg.
Status: Active.
Effective Jul 1, 2024.
Source: CMS HCPCS Level II.
J2267
ActiveInj, mirikizumab-mrkz, 1 mg
Injection, mirikizumab-mrkz, 1 mg
Category:
Drugs
Section:
J-codes: Drugs Administered Other Than Oral Method
Effective:
Jul 1, 2024
Code type:
alphanumeric
OPPS Status:
G
— Pass-through drugs and biologicals
OPPS APC:
0728
MUE — Medically Unlikely Edits
Maximum units of J2267 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.
| Service Type | Max Units / Day |
|---|---|
| DME Supplier | 900 |
| Outpatient Hospital | 900 |
| Practitioner Services | 900 |
Source: CMS Medicare NCCI Medically Unlikely Edits
NDC Crosswalk
National Drug Codes (NDCs) mapped to this HCPCS code.
| NDC | Drug Name |
|---|---|
| 00002-7575-01 | Omvoh |
| 00002-7717-11 | Omvoh |
| 00002-7722-11 | Omvoh |
| 00002-8011-27 | Omvoh |
| 00002-8870-27 | Omvoh |
Change History
Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.
-
New Code 2024-Q3Inj, mirikizumab-mrkz, 1 mg